Metrics: Quality vs. Quantify and how the game has changed
In this episode, Charlie Cook from Takeda joins Tom Caravela to explore the evolving landscape of MSL metrics before, during, and after COVID. They discuss the origins and strategic alignment of these metrics throughout drug lifecycles and the complexities of tracking them across different territories. The conversation delves into the impact of metrics on MSL behavior, emphasizing flexibility in interactions with Key Opinion Leaders (KOLs) and the challenges of a hybrid work environment. Charlie highlights the crucial role of MSL managers in communicating value and evaluating performance. The episode concludes with insights into essential skills for future MSLs, such as emotional intelligence and effective virtual communication.
Charlie Cook, Director MSLs at Takeda, discusses metrics and how the game has changed since Covid 19
Charlie shares….
👉 His views on Quality vs Quantity
👉 The importance of focusing on strategic goals
👉 Advice for the future of Medical Affairs
👉 Why MSLs need to communicate VALUE
